Almirall is a global biopharmaceutical company focused on medical dermatology. Founded in 1944 and with headquarters in Barcelona (Spain), our purpose is at the core of our work: “Transform the patients’ world by helping them realize their hopes and dreams for a healthy life”. Through pharmaceutical innovation, investment in R&D and strong commitment to global healthcare partnerships, we develop and commercialize solutions with specific focus on dermatological diseases such as psoriasis, actinic keratosis, atopic dermatitis or acne. We care and listen to our patients’ needs. We find solutions for them. We aim to empower them. Almirall has 1 R&D center, 2 chemical plants and 2 pharmaceutical plants. Our more than 1,900 employees make it possible for our treatments to be available in over 100 countries across 5 continents, through our 15 global affiliates and via a strategic partnership network. Almirall is listed on the Spanish Stock Exchange (ticker: ALM).
解鎖市場時間軸與訊號動態
過去 90 日內有 39 個訊號。
此公司進入各市場的次序 — 由最舊至最新
14 active postings
Facharztaußendienst Dermatologie (Biologika) (m/w/d), Region L1: Dresden, Cottbus, Görlitz, Wittenberg
註冊以查看完整訊號動態
Almirall 的國際擴張與競爭對手的比較
Almirall你長條顯示所比較各公司之間的相對規模。
欄位5| 公司 | 市場 | 新市場 | 動能 | 活動 | 擴張評分 |
|---|---|---|---|---|---|
 Almirall你 | 3 | 0 | +38% | 38 | 30 |
Product Manager (m/w/d) Atopic Dermatitis (AD)
查看招聘Hamburg, Hamburg, Germany · 3日前
MEDICAL AFFAIRS SENIOR MANAGER Temporary
查看招聘Barcelona, Catalonia, Spain · 4日前
IT BUSINESS PROCESS MANAGER
查看招聘Sant Andreu de la Barca, Catalonia, Spain · 6日前
At Almirall, our "Act4Impact" strategy is the blueprint that integrates five vital pillars into our daily operations. This framework ensures our growth in medical dermatology is as responsible as it is innovative. Our commitment to a positive legacy includes: - Planet: A science-led roadmap toward Net Zero emissions. -People: Fostering a diverse and inclusive culture where our teams lead with integrity. - Patients: Placing people living with skin conditions at the core of every decision. - Part ...
已結束For those living with chronic skin conditions, physical symptoms are only one part of the journey. Psychological distress, social isolation, and sleep disturbances can persist even after skin clearance. At Almirall, we aim to lead a paradigm shift. By integrating the WHO-5 Well-being Index into our clinical trials, we demonstrate our commitment to placing patient wellbeing at the heart of everything we do. Our goal is to transform the patient's world - addressing the person that lives behind the ...
已結束For those living with chronic skin conditions, physical symptoms are only one part of the journey. Psychological distress, social isolation, and sleep disturbances can persist even after skin clearance. At Almirall, we aim to lead a paradigm shift. By integrating the WHO-5 Well-being Index into our clinical trials, we demonstrate our commitment to placing patient wellbeing at the heart of everything we do. Our goal is to transform the patient's world - addressing the person that lives behind the ...
已結束Almirall 股東重選 Carlos Gallardo 為首席執行官，Enrique de Leyva 為副總裁。公司將派發每股 0.19 歐元的靈活股息。
Qualifyze推出質量洞察平台，這是一個基於全球最大審計數據庫的人工智能驅動工具，用於製藥風險管理。
解鎖已驗證電郵與直撥電話
免費 · 無需信用卡
關於 Almirall 業務、市場及增長訊號的快速解答。
